PT. Penta Valent Tbk (IDX:PEVE)
Indonesia · Delayed Price · Currency is IDR 316.00
+2.00 (0.64%)
Last updated: Sep 2, 2026, 11:58 AM WIB
PT. Penta Valent Tbk Revenue
PT. Penta Valent Tbk had revenue of 965.30B IDR in the quarter ending June 30, 2026, with 14.15% growth. This brings the company's revenue in the last twelve months to 3.70T, up 13.01% year-over-year. In the year 2025, PT. Penta Valent Tbk had annual revenue of 3.55T with 17.77% growth.
Revenue (ttm)
3.70T
Revenue Growth
+13.01%
P/S Ratio
0.15
Revenue / Employee
2.46B
Employees
1,504
Market Cap
554.41B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.55T | 535.25B | 17.77% |
| Dec 31, 2024 | 3.01T | 528.07B | 21.25% |
| Dec 31, 2023 | 2.48T | 337.34B | 15.71% |
| Dec 31, 2022 | 2.15T | 359.31B | 20.10% |
| Dec 31, 2021 | 1.79T | 407.33B | 29.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 37.72T |
| PT Siloam International Hospitals Tbk | 13.51T |
| PT Mitra Keluarga Karyasehat Tbk | 5.57T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.70T |
| PT Itama Ranoraya Tbk | 1.05T |
| PT Esa Medika Mandiri Tbk | 504.59B |
| PT Royal Prima Tbk | 320.78B |
| PT UBC Medical Indonesia Tbk | 207.82B |